Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience, Inc., a leading global drug discovery and development service company, today announced its HuPrime® PDX (Patient-Derived Xenograft) model collection has now passed the 1,000 individual models mark.
read more
Wednesday, September 17, 2025
Crown Bioscience announced the opening of a state-of-the-art model development center in Kannapolis, North Carolina. This strategic investment expands the company’s operations and enhances its ability to deliver advanced preclinical oncology models, ...
read more
Crown Bioscience announced the appointment of Dr. Leon Hall as Vice President of Global Scientific Excellence.
read more
Wednesday, January 13, 2016
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of Eric Murphy, Ph.D., as global scientific director for ...
read more
Wednesday, September 27, 2017
Crown Bioscience announced the appointment of Laurie Heilmann as Chief Business Officer.
read more
Wednesday, March 30, 2016
Crown Bioscience Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, is announcing the launch ...
read more
Wednesday, September 07, 2016
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance metabolic disease and oncology research, will be announcing the release of its new translational platforms for metabolic disease ...
read more
Thursday, September 22, 2016
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has published a further ...
read more
Crown Bioscience, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch of HuScreenTM, a new Translational Oncology service platform ...
read more
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch...
read more
Wednesday, April 19, 2017
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has launched an e-...
read more
Tuesday, January 09, 2018
CrownSyn is now available as an add-on feature to all two-drug combinatorial studies conducted by Crown Bioscience.
read more
Tuesday, October 20, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of two respected industry veterans to its business ...
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has expanded its San Diego facility to create CrownBio’s U.S. Center of Excellence for ...
read more